Omega Therapeutics (OMGAQ) Short Interest Ratio & Short Volume $0.0020 +0.00 (+150.00%) As of 08/7/2025 01:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock Omega Therapeutics Short Interest DataOmega Therapeutics (OMGAQ) has a short interest of 338,400 shares. This marks a 29.46% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 306,853 shares to cover all short positions.Current Short Interest338,400 sharesPrevious Short Interest261,400 sharesChange Vs. Previous Month+29.46%Dollar Volume Sold Short$21.08 thousandShort Interest Ratio0.1 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares55,370,000 sharesPercentage of Shares Shorted0.61%Today's Trading Volume97,423 sharesAverage Trading Volume306,853 sharesToday's Volume Vs. Average32% Short Selling Omega Therapeutics? Sign up to receive the latest short interest report for Omega Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOMGAQ Short Interest Over TimeOMGAQ Days to Cover Over TimeOMGAQ Percentage of Float Shorted Over Time Omega Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/2025338,400 shares $21.08 thousand +29.5%N/A0.1 $0.06 1/31/20255,210,000 shares $2.55 million +5.3%27.0%0.9 $0.49 1/15/20254,950,000 shares $3.14 million -3.7%25.6%14.4 $0.63 12/31/20245,140,000 shares $3.83 million -6.0%26.6%15.4 $0.75 12/15/20245,470,000 shares $5.30 million -3.5%28.3%17.6 $0.97 11/30/20245,670,000 shares $5.01 million -11.1%29.5%18.8 $0.88 11/15/20246,380,000 shares $5.29 million +0.3%33.2%22.6 $0.83 10/31/20246,360,000 shares $7.38 million +5.5%31.1%26.5 $1.16 10/15/20246,030,000 shares $5.39 million +7.5%29.5%25 $0.89 9/30/20245,610,000 shares $6.84 million -0.2%27.4%27.2 $1.22 Get the Latest News and Ratings for OMGAQ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Omega Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 9/15/20245,620,000 shares $7.47 million +0.9%27.5%18.5 $1.33 8/31/20245,570,000 shares $8.19 million -0.7%27.2%15.4 $1.47 8/15/20245,610,000 shares $8.58 million +5.1%27.4%13.3 $1.53 7/31/20245,340,000 shares $9.93 million No Change26.1%11.4 $1.86 7/15/20245,340,000 shares $10.41 million -5.2%26.1%11.2 $1.95 6/30/20245,630,000 shares $11.65 million +7.4%27.5%11.7 $2.07 6/15/20245,240,000 shares $10.64 million +0.6%25.6%12.7 $2.03 5/31/20245,210,000 shares $10.32 million +5.0%25.4%13.9 $1.98 5/15/20244,960,000 shares $11.31 million +10.2%24.2%13.4 $2.28 4/30/20244,500,000 shares $10.04 million +1.6%22.0%11.1 $2.23 4/15/20244,430,000 shares $11.14 million +9.7%21.7%9.6 $2.52 3/31/20244,040,000 shares $14.75 million +4.1%19.8%5.3 $3.65 3/15/20243,880,000 shares $14.05 million +4.3%19.0%1.8 $3.62 2/29/20243,720,000 shares $15.29 million +12.4%18.2%1.8 $4.11 2/15/20243,310,000 shares $14.07 million +5.8%16.2%1.6 $4.25 1/31/20243,130,000 shares $11.42 million -13.5%14.7%1.6 $3.65 1/15/20243,620,000 shares $15.75 million +138.2%17.0%1.9 $4.35 12/31/20231,520,000 shares $4.58 million +2.7%7.1%0.9 $3.01 12/15/20231,480,000 shares $3.66 million -11.9%6.9%5.9 $2.47 11/30/20231,680,000 shares $3.85 million +0.6%7.9%7.5 $2.29 11/15/20231,670,000 shares $3.11 million -13.0%7.8%8.6 $1.86 10/31/20231,920,000 shares $2.63 million -6.8%9.0%10.3 $1.37 10/15/20232,060,000 shares $3.61 million +7.9%9.7%14 $1.75 9/30/20231,910,000 shares $4.11 million -11.2%9.0%13.8 $2.15 9/15/20232,150,000 shares $7.10 million +4.9%10.1%12.9 $3.30 8/31/20232,050,000 shares $7.52 million +12.6%9.6%11.9 $3.67 8/15/20231,820,000 shares $6.30 million +4.0%8.6%10.5 $3.46 7/31/20231,750,000 shares $9.78 million +7.4%8.2%10.2 $5.59 7/15/20231,630,000 shares $7.53 million +15.6%7.6%9.9 $4.62 6/30/20231,410,000 shares $7.90 million +33.0%6.6%8.8 $5.60Altucher: Trump’s Great Gain is starting (Ad)New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun. Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation.See Altucher’s Trump crypto prediction here 6/15/20231,060,000 shares $8.43 million +1.0%5.0%7 $7.95 5/31/20231,050,000 shares $7.97 million +8.2%6.4%10.4 $7.59 5/15/2023970,900 shares $8.23 million -1.9%6.7%10.3 $8.48 4/30/2023989,900 shares $7.58 million +7.2%6.5%10.5 $7.66 4/15/2023923,600 shares $6.98 million +34.0%6.0%10.2 $7.56 3/31/2023689,300 shares $4.16 million +65.1%4.5%7.2 $6.03 3/15/2023417,600 shares $2.83 million +10.8%2.7%5.2 $6.78 2/28/2023376,800 shares $2.43 million -5.0%2.2%5.9 $6.46 2/15/2023396,800 shares $2.20 million +14.3%2.0%6.6 $5.55 1/31/2023347,200 shares $2.73 million +6.3%2.0%6.1 $7.85 1/15/2023326,600 shares $2.83 million +3.5%1.8%6.6 $8.65 12/30/2022315,700 shares $1.80 million +0.1%1.8%8.2 $5.71 12/15/2022315,500 shares $1.92 million -3.9%1.8%7.3 $6.10 11/30/2022328,300 shares $2.30 million -6.4%1.9%5 $7.00 11/15/2022350,800 shares $2.17 million -6.7%2.0%5.4 $6.20 10/31/2022375,900 shares $1.81 million +2.2%2.1%5.2 $4.81 10/15/2022368,000 shares $1.69 million +15.0%2.1%4.7 $4.60 9/30/2022320,100 shares $1.73 million +15.3%1.8%3.8 $5.42 9/15/2022277,600 shares $1.71 million -14.0%1.6%2 $6.17 8/31/2022322,900 shares $1.44 million -13.6%1.8%2.4 $4.47 8/15/2022373,900 shares $1.87 million -14.9%2.1%2.3 $5.00 7/31/2022439,400 shares $2.24 million -18.5%2.5%2.5 $5.10 7/15/2022538,800 shares $2.32 million -24.3%3.1%2.8 $4.31 6/30/2022711,900 shares $2.71 million -37.0%4.1%3.6 $3.80 6/15/20221,130,000 shares $3.17 million +1.8%6.5%5.9 $2.81 5/31/20221,110,000 shares $2.52 million +5.7%6.4%6.1 $2.27 5/15/20221,050,000 shares $3.01 million +41.3%6.0%6.4 $2.87 4/30/2022743,000 shares $2.53 million -29.9%4.3%4.5 $3.41 4/15/20221,060,000 shares $6.22 million -17.2%6.1%7.3 $5.87 3/31/20221,280,000 shares $7.99 million +48.3%7.3%9.2 $6.24 3/15/2022863,100 shares $6.99 million +16.4%5.0%6.1 $8.10 2/28/2022741,600 shares $8.80 million +6.3%4.3%6.9 $11.87 2/15/2022697,500 shares $7.91 million -3.3%4.0%6.9 $11.34 1/31/2022721,400 shares $8.20 million +5.8%4.1%8.4 $11.36 1/15/2022681,700 shares $7.27 million +9.1%3.9%7.7 $10.66 12/31/2021624,700 shares $7.08 million No Change3.6%6.8 $11.33 OMGAQ Short Interest - Frequently Asked Questions What is Omega Therapeutics' current short interest? Short interest is the volume of Omega Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 338,400 shares of OMGAQ short. Learn More on Omega Therapeutics' current short interest. Is Omega Therapeutics' short interest increasing or decreasing? Omega Therapeutics saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 338,400 shares, an increase of 29.5% from the previous total of 261,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Omega Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Omega Therapeutics: CNS Pharmaceuticals, Inc. (6.93%), Tharimmune, Inc. (0.63%), Redhill Biopharma Ltd. (1.07%), NovaBay Pharmaceuticals, Inc. (0.66%), SciSparc Ltd. (3.18%), Evaxion A/S - Sponsored ADR (9.25%), Titan Pharmaceuticals, Inc. (0.91%), Mosaic ImmunoEngineering Inc. (0.01%), Windtree Therapeutics, Inc. (71.04%), Galmed Pharmaceuticals Ltd. (6.25%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Omega Therapeutics stock? Short selling OMGAQ is an investing strategy that aims to generate trading profit from Omega Therapeutics as its price is falling. OMGAQ shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Omega Therapeutics? A short squeeze for Omega Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OMGAQ, which in turn drives the price of the stock up even further. How often is Omega Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OMGAQ, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies CNSP Short Interest THAR Short Interest RDHL Short Interest NBY Short Interest SPRC Short Interest EVAX Short Interest TTNP Short Interest CPMV Short Interest WINT Short Interest GLMD Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:OMGAQ) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omega Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omega Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OMGAQ Stock Alerts